AZN - AstraZeneca beats top-line and bottom-line estimates; initiates FY24 outlook February, 08 2024 02:23 AM AstraZeneca PLC 2024-02-08 02:23:16 ET AstraZeneca's Q4 Earnings: Recognizing The Underrated Gem's Growth Why AstraZeneca's Gracell Biotechnologies Acquisition Is A Win-Win AstraZeneca: A $1.1B Shot In The Arm From Icosavax Acquisition AstraZeneca to invest $300M in new US cell therapy plant For further details see: AstraZeneca beats top-line and bottom-line estimates; initiates FY24 outlook